Overview

Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

Status:
Recruiting

Trial end date:
2022-06-01

Target enrollment:

Participant gender:

Summary

The goal of this fixed order, open-label, dose-escalation study is to investigate the safety and efficacy of specific doses of dimethyltryptamine (DMT) in humans.

Phase:

Phase 1

Details

Lead Sponsor:

Yale University

Treatments:

N,N-Dimethyltryptamine